Form 4 for OKUR OnKure Therapeutics, Inc.
Accepted 2022-09-02 00:00:00 ET · period of report 2022-08-31 · accession 0001209191-22-048532 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-09-02 | 2022-08-31 | OKUR | GREY MICHAEL G | Executive COB, Dir | M - OptEx | $1.97 | +50.0K | 50.0K | New | +$98.5K |
| D | 2022-09-02 | 2022-08-31 | OKUR | GREY MICHAEL G | Executive COB, Dir | M - OptEx | $0.00 | -50.0K | 67.4K | -43% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-08-31 | M | A | 50,000 | $1.97 | 50,000 | D | — | — | |
| 2 | Derivative | Stock option (right to buy) | 2022-08-31 | M | D | 50,000 | $0.00 | 67,406 | D | $1.97 · 2019-01-01 to 2028-04-04 | 50,000 Common Stock |